Imaging of Vitreous Opacities in a Canadian Population

N/ACompletedNCT06204848

PulseMedica44 enrolled

Overview

The goal of this clinical trial is to capture imaging data of eye floaters in the population to build an imaging database to learn more about them in. Participants will imaged with an investigational ophthalmic imaging device to capture images of their floaters.

Study Type

INTERVENTIONAL

Allocation

Purpose

OTHER

Masking

NONE

Enrollment

Conditions

Floaters Vitreous Opacities

Interventions

SVO-IDDEVICE

Combined scanning laser ophthalmoscope (SLO) and optical coherence tomography (OCT) for imaging of the eye

Eligibility

Sex: ALLMin age: 18 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * Aged 18 years or older * Symptomatic vitreous opacities (floaters) in vision * Clear ocular media, to allow a clear view of the vitreous for the SVO-ID Exclusion Criteria: * Younger than 18 years of age * Presence of vitreous hemorrhage * Cataract Grade 3 and above * Opacification of lens, cornea, or vitreous * Diagnosis of narrow angle glaucoma * Refractive error is outside the range of -6D to+3D * Astigmatism is outside the range of +/-2D of cylinder

Locations (1)

Alberta Retina Consultants

Edmonton, Alberta, Canada

Outcomes

Primary Outcomes

Successful capture of SLO and OCT imaging data of SVOs for algorithm development

Successful collection of SLO and OCT imaging data

Time frame: Through study completion, an average of 6-8 months

Secondary Outcomes

Collection of patient-reported symptoms

Patient feedback regarding symptoms related to SVOs being imaged

Time frame: Through study completion, an average of 6-8 months

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.